Form 4: Health In Tech CGO Executes Tax-Related Share Disposition
Statement of Changes in Beneficial Ownership
Chief Growth Officer Zain Hasan disposed of 3,448 shares of Class A Common Stock to satisfy tax withholding obligations.
Summary
- Zain Hasan, Chief Growth Officer of Health In Tech, Inc., reported the disposition of 3,448 shares of Class A Common Stock.
- The transaction occurred on April 15, 2026, at a price of $1.50 per share.
- The disposition was made to satisfy tax withholding and remittance obligations related to the vesting of previously granted restricted stock.
- Following this transaction, the reporting person maintains beneficial ownership of 216,552 shares, consisting of 211,552 restricted shares and 5,000 unrestricted shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the share disposition is purely administrative and related to tax compliance rather than a change in management sentiment.
Positives
- The transaction is a routine administrative action related to tax obligations rather than a discretionary sale of equity.
- The reporting person retains a significant equity stake of 216,552 shares in the company.
Negatives
- The transaction results in a minor reduction of the officer's direct share ownership.
Risks
- None identified; this is a standard regulatory filing for tax compliance.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Management Comments
- The reporting person confirmed the transaction was for tax withholding and remittance obligations in connection with the vesting of restricted shares.
Industry Context
StockSavvy.ai notes that this filing is a standard administrative disclosure common in the healthcare technology sector, where equity-based compensation is frequently used to align executive interests with long-term performance.
Comparison to Industry Standards
- The use of 'sell-to-cover' transactions to satisfy tax obligations upon the vesting of restricted stock units is a standard practice among publicly traded companies.
- The disclosure complies with SEC Section 16(a) reporting requirements, consistent with industry norms for executive compensation management.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a routine tax-related event.
Next Steps
- Continued compliance with Section 16(a) reporting requirements for future transactions.
Key Dates
| Date | Description |
|---|---|
| 2026-01-08 | Original grant of restricted stock reported on Form 4. |
| 2026-04-15 | Date of the reported transaction involving share disposition. |
| 2026-04-17 | Date of filing for the Form 4 and Power of Attorney. |
Keywords
Health In Tech, HIT, Form 4, Insider Trading, Tax Withholding, Equity Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.